BIVDA Press Releases

In an NHS career spanning over 42 years, Angela was most recently the Deputy Chief Scientific Officer for NHS England until retiring from the role in October 2023. Angela brings a unique perspective to the Association, with her experience including; providing scientific oversight to the AMR diagnostics team in the Office of the Chief Scientific Officer, and working alongside NHS Test and Trace in COVID-19 laboratory development, product assay development, technical validation and providing scien...

BIVDA has noted the latest changes in the Prime Minister’s Cabinet and ministerial team. We would like to welcome the new Secretary of State for Health and Social Care, Victoria Atkins.  

The British In Vitro Diagnostic Association (BIVDA) today announced the appointment of Helen Dent as Interim Chief Executive Officer. Helen will replace outgoing CEO, Doris-Ann Williams, who has retired from her role. Helen will lead the organisation in championing the in vitro diagnostics (IVD) industry to politicians, policymakers, media and relevant stakeholders and in supporting members to improve patient outcomes. Helen, who will step into the role following over three years as Chief Operat...

Doris-Ann Williams has retired from her role as Chief Executive at BIVDA, after almost 22 years. Doris-Ann said, “I have been privileged to do a job I have loved representing the industry I am passionate about. It has been wonderful to see the value of diagnostics and laboratory medicine increase in profile in UK healthcare during the last 20 years, although there is still more to be done. I am now looking forward to starting a new chapter in my life and wish BIVDA continued success in the...

The British In Vitro Diagnostics Association (BIVDA) has today launched a new independent whitepaper which examines the UK genomics landscape, with a focus on patient access to genomic testing.

The British In Vitro Diagnostics Association (BIVDA) commissioned the University of Nottingham to produce an independent White Paper examining the UK Government’s procurement of Covid-19 tests during the pandemic, which has been released today.

The Department of Health and Social Care published the first strategy for medical technology today. The British In Vitro Diagnostics Association (BIVDA) welcomes this as another step forward to achieving wider use of the essential diagnostic tests and enabling technology which can really support better healthcare for patients and save resource for the NHS.

BIVDA welcomes MHRA’s formal response to the consultation on future regulation of medical devices in the UK The response to the consultation on the new UK Regulatory Framework for medical devices was published on 26 June 2022. This is a huge step for regulation in the UK and gives an insight into what can be expected when the regulations are published. Totalling 16 chapters and spanning 155 pages, the response is very comprehensive and detailed. This depth has been anticipated by the ...

BIVDA welcomes the In Vitro Diagnostic Medical Devices Regulation and urges continued work to deploy the new regulatory system.

BIVDA, the UK’s in vitro diagnostics trade association, has commented on the passing of the Health and Care Bill into law which took place yesterday.  Our 200+ IVD member companies supply or support key diagnostic technologies and stand-alone products to the NHS. Stability of these supply chains, commissioning processes and specifics regarding purchase tenders are critical factors to the protection of UK diagnostic care and optimised patient outcomes.  We support the integration ...